|
1
|
Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
|
Science
|
2009
|
3.39
|
|
2
|
High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors.
|
PLoS Pathog
|
2009
|
2.76
|
|
3
|
Global analysis of the Mycobacterium tuberculosis Zur (FurB) regulon.
|
J Bacteriol
|
2006
|
2.33
|
|
4
|
Role of mycobacterial efflux transporters in drug resistance: an unresolved question.
|
FEMS Microbiol Rev
|
2006
|
2.02
|
|
5
|
New tuberculosis drugs on the horizon.
|
Curr Opin Microbiol
|
2011
|
1.94
|
|
6
|
Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis.
|
Sci Transl Med
|
2012
|
1.78
|
|
7
|
Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis.
|
Antimicrob Agents Chemother
|
2004
|
1.64
|
|
8
|
The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis.
|
Mol Med
|
2002
|
1.58
|
|
9
|
Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.
|
J Am Chem Soc
|
2011
|
1.33
|
|
10
|
Mycobacterium tuberculosis FurA autoregulates its own expression.
|
J Bacteriol
|
2003
|
1.32
|
|
11
|
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance.
|
BMC Microbiol
|
2009
|
1.30
|
|
12
|
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.
|
BMC Microbiol
|
2006
|
1.26
|
|
13
|
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system.
|
Tuberculosis (Edinb)
|
2008
|
1.24
|
|
14
|
mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis.
|
Antimicrob Agents Chemother
|
2005
|
1.23
|
|
15
|
Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms.
|
Antimicrob Agents Chemother
|
2011
|
1.22
|
|
16
|
The Mycobacterium tuberculosis Rv2358-furB operon is induced by zinc.
|
Res Microbiol
|
2004
|
1.19
|
|
17
|
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia.
|
PLoS One
|
2011
|
1.14
|
|
18
|
Development of a repressible mycobacterial promoter system based on two transcriptional repressors.
|
Nucleic Acids Res
|
2010
|
1.13
|
|
19
|
Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance.
|
Mol Microbiol
|
2010
|
1.12
|
|
20
|
Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinones.
|
Antimicrob Agents Chemother
|
2010
|
1.05
|
|
21
|
Rv2358 and FurB: two transcriptional regulators from Mycobacterium tuberculosis which respond to zinc.
|
J Bacteriol
|
2005
|
1.02
|
|
22
|
Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species.
|
PLoS One
|
2013
|
1.01
|
|
23
|
Transcriptional analysis of ESAT-6 cluster 3 in Mycobacterium smegmatis.
|
BMC Microbiol
|
2009
|
0.97
|
|
24
|
Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium.
|
Appl Microbiol Biotechnol
|
2011
|
0.90
|
|
25
|
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis.
|
Antimicrob Agents Chemother
|
2006
|
0.88
|
|
26
|
Heterologous expression, purification, and enzymatic activity of Mycobacterium tuberculosis NAD(+) synthetase.
|
Protein Expr Purif
|
2002
|
0.87
|
|
27
|
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates.
|
Microb Drug Resist
|
2011
|
0.86
|
|
28
|
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis.
|
PLoS One
|
2011
|
0.86
|
|
29
|
Exploring the HME and HAE1 efflux systems in the genus Burkholderia.
|
BMC Evol Biol
|
2010
|
0.85
|
|
30
|
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator.
|
J Bacteriol
|
2009
|
0.85
|
|
31
|
Phenotypic and genotypic characterisation of Burkholderia cenocepacia J2315 mutants affected in homoserine lactone and diffusible signal factor-based quorum sensing systems suggests interplay between both types of systems.
|
PLoS One
|
2013
|
0.85
|
|
32
|
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis.
|
ACS Chem Biol
|
2014
|
0.83
|
|
33
|
Mechanism of action of 5-nitrothiophenes against Mycobacterium tuberculosis.
|
Antimicrob Agents Chemother
|
2014
|
0.83
|
|
34
|
A census of RND superfamily proteins in the Burkholderia genus.
|
Future Microbiol
|
2013
|
0.82
|
|
35
|
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia.
|
Antimicrob Agents Chemother
|
2014
|
0.82
|
|
36
|
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
|
J Med Chem
|
2014
|
0.82
|
|
37
|
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain.
|
Res Microbiol
|
2005
|
0.81
|
|
38
|
Retracted
Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art.
|
Appl Microbiol Biotechnol
|
2012
|
0.79
|
|
39
|
Mycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesis.
|
PLoS One
|
2010
|
0.78
|
|
40
|
Techniques and applications: The heterologous expression of Mycobacterium tuberculosis genes is an uphill road.
|
Trends Microbiol
|
2003
|
0.76
|
|
41
|
DprE1, a new taxonomic marker in mycobacteria.
|
FEMS Microbiol Lett
|
2013
|
0.76
|
|
42
|
Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesin from Streptococcus dysgalactiae.
|
Biochim Biophys Acta
|
2003
|
0.75
|
|
43
|
A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors.
|
ACS Infect Dis
|
2017
|
0.75
|